BRIEF published on 06/08/2026 at 07:05, 3 months 10 days ago ADOCIA presents promising results for BioChaperone® Lispro Positive Results Phase 3 Type 2 Diabetes BioChaperone Lispro Blood Glucose Control
BRIEF published on 06/08/2026 at 07:05, 3 months 10 days ago Adocia's BioChaperone® Lispro: Promising Phase 3 Results Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro Glycemic Control
PRESS RELEASE published on 06/08/2026 at 07:00, 3 months 10 days ago Inside Information / Other news releases Adocia announces positive Phase 3 results of BioChaperone® Lispro for type 2 diabetes, presenting superior glycemic control benefits over Humalog® Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro ADA 86th Scientific Session
BRIEF published on 04/21/2026 at 20:35, 4 months 26 days ago Adocia Reports 2025 Financial Results and Strategic Developments Corporate Governance Financial Results 2025 Biopharmaceutical Advancements BioChaperone® Technology Partnerships And Patents
PRESS RELEASE published on 04/21/2026 at 20:30, 4 months 26 days ago Inside Information / News release on accounts, results ADOCIA announces full year 2025 financial results, highlights positive Phase 3 results for diabetes treatment, and secures cash runway until Q2 2027. Company advancements in key technology platforms showcased Financial Results Diabetes Treatment Phase 3 Results ADOCIA Technology Platforms
BRIEF published on 04/21/2026 at 19:35, 4 months 26 days ago ADOCIA concludes a financial agreement with Vester Finance Treasury Funding Biopharmaceutical ADOCIA Vester Finance
BRIEF published on 04/21/2026 at 19:35, 4 months 26 days ago ADOCIA Secures €6 Million Shareholder Loan from Vester Finance Shareholder Loan Cash Runway ADOCIA BioChaperone® Vester Finance
PRESS RELEASE published on 04/21/2026 at 19:30, 4 months 26 days ago Inside Information / Other news releases Adocia secures €6.0 million shareholder loan from Vester Finance, extending cash runway until Q2 2027. Funds for BioChaperone and AdoXLong development Shareholder Loan ADOCIA Vester Finance Cash Runway Extension BioChaperone
BRIEF published on 12/08/2025 at 19:35, 9 months 9 days ago ADOCIA Announces Share and Voting Rights Update Voting Rights Shares Financial Disclosure Diabetes Treatment ADOCIA
PRESS RELEASE published on 12/08/2025 at 19:30, 9 months 9 days ago Inside Information / Other news releases Adocia SA releases total number of shares and voting rights as of December 8th, 2025. Company focuses on innovative therapeutic solutions for diabetes and obesity Voting Rights Shares Diabetes Obesity ADOCIA
Published on 09/18/2026 at 13:30, 36 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 7 hours 36 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 13 hours 11 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 13 hours 41 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/18/2026 at 13:52, 14 minutes ago New rules for green claims. Does eco-friendly also mean animal-friendly?
Published on 09/18/2026 at 13:51, 15 minutes ago Completion of the Acquisition of a Majority Stake in Jucari Global Pty Ltd
Published on 09/18/2026 at 13:50, 16 minutes ago Omio expands premium overnight travel options with Twiliner
Published on 09/18/2026 at 13:30, 36 minutes ago EQS-Adhoc: Sibanye Gold Limited: Notice to Bondholders
Published on 09/18/2026 at 13:30, 36 minutes ago EQS-Adhoc: Avemio AG: Preliminary Revenue and Earnings Figures for Fiscal Year 2025
Published on 09/17/2026 at 17:40, 20 hours 26 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 20 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 7 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
